Please use this identifier to cite or link to this item: http://hdl.handle.net/1893/29851
Appears in Collections:Aquaculture Journal Articles
Peer Review Status: Refereed
Title: Whole cell inactivated autogenous vaccine effectively protects red Nile tilapia (Oreochromis niloticus) against francisellosis via intraperitoneal injection
Author(s): Ramirez-Paredes, José Gustavo
Mendoza-Roldan, Miguel Angel
Lopez-Jimena, Benjamin
Shahin, Khalid
Metselaar, Matthijs
Thompson, Kim D
Penman, David J
Richards, Randolph H
Adams, Alexandra
Contact Email: alexandra.adams@stir.ac.uk
Keywords: autogenous vaccines
Francisella noatunensis subsp. Orientalis
Francisella vaccines
francisellosis in tilapia
tilapia diseases
tilapia vaccines
Issue Date: 11-Jun-2019
Citation: Ramirez-Paredes JG, Mendoza-Roldan MA, Lopez-Jimena B, Shahin K, Metselaar M, Thompson KD, Penman DJ, Richards RH & Adams A (2019) Whole cell inactivated autogenous vaccine effectively protects red Nile tilapia (Oreochromis niloticus) against francisellosis via intraperitoneal injection. Journal of Fish Diseases. https://doi.org/10.1111/jfd.13041
Abstract: Francisella noatunensis subsp. orientalis is a pathogen of tilapia and other warm‐water fish for which no vaccines are commercially available. In this study, a whole cell formalin‐inactivated vaccine was developed for the first time using the highly virulent isolate STIR‐GUS‐F2f7 and the oil‐based adjuvant Montanide™ ISA 763A VG. The efficacy of the vaccine was assessed in red Nile tilapia via intraperitoneal (i.p.) injection using homologous experimental infection and correlates of protection such as seral antibody production and bacterial loads in the spleen. For immunization, fish were i.p. injected with 0.1 ml of the vaccine, the adjuvant alone or PBS. At 840 degree days post‐vaccination, all fish were i.p. injected with 4.0 × 103 CFU/fish of pathogenic bacteria. The RPS at the end of the trial was 100% in the vaccinated group with significantly higher survival than in the adjuvant and control groups. The RPS in the adjuvant group was 42%, and no significant difference was seen in survival between this and the PBS group. Moreover, significantly higher antibody titres in the serum and significantly lower bacterial loads in the spleen were detected in the vaccinated fish by ELISA and qPCR, respectively. These findings highlight the potential of autogenous vaccines for controlling francisellosis in tilapia.
DOI Link: 10.1111/jfd.13041
Rights: This item has been embargoed for a period. During the embargo please use the Request a Copy feature at the foot of the Repository record to request a copy directly from the author. You can only request a copy if you wish to use this work for your own research or private study.
Notes: Output status: Forthcoming/Available Online

Files in This Item:
File Description SizeFormat 
Francisella_Vaccine_Paper_Ramirez-Paredes_et_al_2019.pdfFulltext - Accepted Version389.31 kBAdobe PDFUnder Embargo until 2020-06-12    Request a copy

Note: If any of the files in this item are currently embargoed, you can request a copy directly from the author by clicking the padlock icon above. However, this facility is dependent on the depositor still being contactable at their original email address.



This item is protected by original copyright



Items in the Repository are protected by copyright, with all rights reserved, unless otherwise indicated.

If you believe that any material held in STORRE infringes copyright, please contact library@stir.ac.uk providing details and we will remove the Work from public display in STORRE and investigate your claim.